Drug Profile
Celivarone
Alternative Names: SSR 149744; SSR 149744B; SSR 149744CLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator sanofi-aventis
- Developer Sanofi
- Class Antiarrhythmics; Benzofurans
- Mechanism of Action Ion channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Supraventricular arrhythmias; Ventricular arrhythmias
Most Recent Events
- 31 Dec 2011 Discontinued - Phase-II for Ventricular arrhythmias in Argentina (PO) during 2011
- 31 Dec 2011 Discontinued - Phase-II for Ventricular arrhythmias in Australia (PO) during 2011
- 31 Dec 2011 Discontinued - Phase-II for Ventricular arrhythmias in Belgium (PO) during 2011